Citadel Advisors - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is and the CUSIP is 00448Q901. A total of 5 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$315,000
+17.1%
40,400
+16.1%
0.00%
Q1 2016$269,000
+3.5%
34,800
+44.4%
0.00%
Q4 2015$260,000
+36.1%
24,100
-12.7%
0.00%
Q3 2015$191,000
-57.6%
27,600
-45.8%
0.00%
Q2 2015$451,000
-5.5%
50,900
+5.2%
0.00%
Q1 2015$477,000
-74.3%
48,400
-68.1%
0.00%
-100.0%
Q4 2014$1,857,000
+141.8%
151,600
+96.9%
0.00%
+100.0%
Q3 2014$768,000
+54.8%
77,000
+17.6%
0.00%0.0%
Q2 2014$496,000
+281.5%
65,500
+65.4%
0.00%
Q1 2014$130,000
+3.2%
39,600
+4.5%
0.00%
Q4 2013$126,000
-24.6%
37,900
-31.6%
0.00%
Q3 2013$167,000
+317.5%
55,400
+1030.6%
0.00%
Q2 2013$40,0004,9000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 9,039$7,322,0000.27%
GROUP ONE TRADING, L.P. 67,900$550,0000.01%
SIMPLEX TRADING, LLC 548$29,0000.00%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders